Lundbeckfonden investerer 150 mio kr i britisk medicoselskab

Lundbeckfonden Ventures skyder 150 mio. kr. i britiske Dysis Medical, som har udviklet et kolposkop, der bruges til at diagnosticere livmoderhalskræft.

Mette Kirstine Agger, ledende partner i Lundbeckfonden Ventures. | Photo: Lundbeckfonden

Lundbeckfondens ventureselskab satser nu et trecifret millionbeløb på, at det britiske medicoselskab Dysis Medical har ramt plet med sit kolposkop, der bruges i gynækologiske undersøgelser til at identificere livmoderhalskræft.

Lundbeckfonden Ventures har således investeret 150 mio. kr. i Dysis Medical.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Savills IM working hard on first Nordic residential investment

The global property investor has plans to expand its growing portfolio in Denmark with a new asset class, residential real estate, "very soon," says Head of Nordics Peter Broström. The manager still believes in the office and retail sectors, despite the pandemic and rising inflation.

Related articles

Latest news


Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch